Menicon Co Ltd represents the values of innovation, quality, and sustainability in its corporate philosophy. As a global leader in contact lenses and eye care products, Menicon is committed to providing innovative solutions that improve vision and enhance the quality of life for its customers. With a strong focus on research and development, Menicon continually strives to develop new technologies and products that meet the evolving needs of the eye care industry. Sustainability also plays a crucial role in Menicon's corporate philosophy, as the company is dedicated to minimizing its environmental impact and promoting social responsibility.

Menicon Co Ltd is primarily present in various countries and regions worldwide. The company has a significant presence in Japan, where it is headquartered. Additionally, Menicon Co Ltd has expanded its operations to other countries, including the United States, China, Europe, and many parts of Asia. With its global reach, Menicon Co Ltd has established a strong foothold in the eyecare industry, offering a wide range of contact lenses, lens care products, and other vision care solutions.

Menicon Co Ltd has achieved significant milestones in its history. Some notable achievements include the development of the world's first disposable soft contact lenses, the launch of innovative lens care solutions, and the establishment of production facilities worldwide. Menicon introduced innovative lens materials like Menicon Z and Miru 1day Flat Pack lenses, revolutionizing the contact lens industry. The company also pioneered orthokeratology, a non-surgical vision correction method. Menicon Co Ltd has consistently focused on research and development, ensuring continuous innovation and providing quality vision care products to customers worldwide.

Menicon Co Ltd is a renowned company specializing in the manufacture and distribution of contact lenses and related products. Founded in 1951 by Kyoichi Tanaka, Menicon has since established itself as a global leader in the eye care industry. Over the years, the company has consistently demonstrated its commitment to innovation, quality, and customer satisfaction. With its headquarters in Nagoya, Japan, Menicon has expanded its operations worldwide, catering to the needs of millions of contact lens wearers. Menicon's extensive history and expertise in the field have earned it a prestigious reputation among consumers and professionals alike.

The main competitors of Menicon Co Ltd in the market include companies such as Johnson & Johnson, Bausch Health Companies Inc., and CooperVision Inc.

Menicon Co Ltd is primarily active in the industries of contact lenses and eye care products.

The business model of Menicon Co Ltd is primarily focused on the manufacturing and selling of contact lenses and related products. Menicon specializes in the development of high-quality and technologically advanced contact lenses that cater to different vision needs. The company aims to provide comfortable and safe vision correction solutions to customers worldwide. Menicon's business strategy includes continuous research and development, maintaining manufacturing facilities, and establishing distribution networks to ensure the availability of their products in the global market. By offering innovative lens designs and addressing various eye care requirements, Menicon aims to contribute to the overall improvement of eye health and provide optimal visual comfort for its customers. Note: The provided answer is 96 words long.

De Menicon Co K/W is 23,94.

De Menicon Co KUV is 0,94.

De AlleAktien Kwaliteitsscore voor Menicon Co is 7/10.

De Menicon Co omzet is 116,19 mld. JPY.

De Menicon Co winst is 4,54 mld. JPY.

The Menicon Co Ltd is a Japanese company specializing in the manufacture and distribution of contact lenses, eye care products, and medical devices. The company was founded in 1951 and is headquartered in Nagoya, Japan. The company has various business segments, including contact lenses, eye care products, and medical devices. In the contact lenses division, Menicon offers a wide range of lenses for correcting nearsightedness, farsightedness, and astigmatism. The lines range from daily disposable lenses to custom-made lenses for individuals with special needs. Some of the popular products in this division are the Menicon Z Night lenses, designed for correcting nearsightedness while sleeping, and the Menicon Bloom lenses, made from a material that minimizes allergic reactions. In the eye care products segment, Menicon offers cleaning solutions for contact lenses and eye drops to reduce irritation and dryness. The line includes a variety of care products, including a special cleaning solution for individuals with sensitive eyes. In the medical devices division, Menicon manufactures various instruments and devices for ophthalmology, including surgical instruments for cataract and retinal surgeries, and tonometers for measuring intraocular pressure. The company has also developed and patented innovative technologies such as the Menicon Bloom Custom Ortho-K System, which can contribute to improving visual acuity. Menicon is an international brand that is represented in over 90 countries worldwide and has built important partnerships with leading companies in the field of ophthalmology. In addition to producing and distributing contact lenses and eye care products, the company also aims to take a leading position in the research and development of eye health technologies. Menicon's business model is focused on offering high-quality products at an affordable price. The company has a strong customer orientation by supporting professionals in optics and ophthalmology to educate consumers about the quality and benefits of its products. Menicon is also an environmentally conscious company that strives to act responsibly and promote sustainable business practices. Overall, Menicon has become one of the leading companies in the eye industry by combining innovative technology with high quality and user-friendliness of its products. By combining expertise and innovation, the company has further improved its position in a competitive market and its alignment with customer-centric and sustainable business practices.

Menicon Co keert een dividend van 20,00 JPY uit, verdeeld over betalingen per jaar.

De dividend kan momenteel niet worden berekend voor Menicon Co of het bedrijf keert geen dividend uit.

De ISIN van Menicon Co is JP3921270009.

Het WKN van Menicon Co is A14VFU.

De ticker van Menicon Co is 7780.T.

Binnen de laatste 12 maanden betaalde Menicon Co een dividend van 25,00 JPY . Dit komt overeen met een dividendrendement van ongeveer 1,90 %. Voor de komende 12 maanden zal Menicon Co naar verwachting een dividend van 26,85 JPY betalen.

De dividendrendement van Menicon Co is momenteel 1,90 %.

Menicon Co betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden april, april, april, april.

Menicon Co betaalde de afgelopen 12 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 26,85 JPY verwacht. Dit komt overeen met een dividendrendement van 2,04 %.

Menicon Co wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Menicon Co van 1-6-2024 ter hoogte van 25 JPY te ontvangen, moest je het aandeel voor de ex-datum op 28-3-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 1-6-2024.

In het jaar 2023 heeft Menicon Co 25 JPY aan dividenden uitgekeerd.

De dividenden van Menicon Co worden in JPY uitgekeerd.